Amlodipine Besylate
Product Images NDC 53002-3249

5 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 53002-3249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (29d19981 1b28 4824 835b 729881d05ef3 01)

Chemical Structure (29d19981 1b28 4824 835b 729881d05ef3 01)
Chemical structure of amlodipine besylate showing molecular connectivity including a chlorophenyl group and dihydropyridine ring, with an empirical formula notation C6H6O3S at the bottom.*
FDA Label Image

Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo Figure-02 (29d19981 1b28 4824 835b 729881d05ef3 02)

Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo  Kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo 		 Figure-02 (29d19981 1b28 4824 835b 729881d05ef3 02)
A Kaplan-Meier event rate graph comparing Amlodipine versus placebo over 24 months. The X-axis shows time in months, and the Y-axis shows event rate. Two survival curves are labeled "Amlodipine" and "Placebo," with Amlodipine showing a lower event rate over time. Statistical data including a p-value (0.003), hazard ratio (0.691), and 95% confidence interval (0.54 to 0.88) are displayed on the figure.*
FDA Label Image

Figure-03 (29d19981 1b28 4824 835b 729881d05ef3 03)

Figure-03 (29d19981 1b28 4824 835b 729881d05ef3 03)
A forest plot depicting the hazard ratios with 95% confidence intervals across various subgroups of patients in a study comparing Amlodipine to placebo. Subgroups include overall patients, age groups, gender, baseline sitting systolic blood pressure (SBP), baseline vessel disease, vessel stenosis presence, and PCI-stent strata. The plot shows whether results favor Amlodipine or placebo based on hazard ratio values along the x-axis.*
FDA Label Image

Company Logo (29d19981 1b28 4824 835b 729881d05ef3 05)

FDA Label Image

Label Image (Lbl530023249)

Label Image (Lbl530023249)
Amlodipine Besylate 5mg tablets packaging label from RPK Pharmaceuticals, Inc., containing 100 tablets. The label includes directions to take 1 tablet daily or as directed, dosage strength, proprietary name, and space for clinic, prescriber, and patient information. The label also shows multiple NDC numbers related to this product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.